0001437749-18-006795.txt : 20180412
0001437749-18-006795.hdr.sgml : 20180412
20180412211548
ACCESSION NUMBER: 0001437749-18-006795
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180402
FILED AS OF DATE: 20180412
DATE AS OF CHANGE: 20180412
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ANDREWS RONALD ASBURY
CENTRAL INDEX KEY: 0001299153
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37648
FILM NUMBER: 18753025
MAIL ADDRESS:
STREET 1: 5791 VAN ALLEN WAY
CITY: CARLSBAD
STATE: CA
ZIP: 92008
FORMER NAME:
FORMER CONFORMED NAME: Andrews Ronald Asbury
DATE OF NAME CHANGE: 20040730
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: OncoCyte Corp
CENTRAL INDEX KEY: 0001642380
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 271041563
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1010 ATLANTIC AVENUE
STREET 2: SUITE 102
CITY: ALAMEDA
STATE: CA
ZIP: 94501
BUSINESS PHONE: 510-775-0515
MAIL ADDRESS:
STREET 1: 1010 ATLANTIC AVENUE
STREET 2: SUITE 102
CITY: ALAMEDA
STATE: CA
ZIP: 94501
3
1
rdgdoc.xml
FORM 3
X0206
3
2018-04-02
0
0001642380
OncoCyte Corp
OCX
0001299153
ANDREWS RONALD ASBURY
C/O ONCOCYTE CORPORATION
1010 ATLANTIC AVENUE, SUITE 102
ALAMEDA
CA
94501
1
Option to Purchase Common Stock
2.1000
2028-04-01
Common Stock
20000
D
Will become exercisable in four equal installments at the end of each calendar quarter based upon continued service on the board of directors from the date of grant on April 2, 2018.
/s/ Ronald A. Andrews
2018-04-12